Susan Mahony - Oct 10, 2023 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Stock symbol
AXSM
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 08:33 PM
Previous filing
Oct 6, 2023
Next filing
Dec 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +1.5K $0.00 1.5K Oct 10, 2023 Common Stock 1.5K $70.56 Direct F1
transaction AXSM Stock Option (Right to Buy) Award $0 +5.87K $0.00 5.87K Oct 10, 2023 Common Stock 5.87K $70.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, October 10, 2024.
F2 The option will vest in equal annual installments over three years such that the option will be fully vested on October 10, 2026.